KYNTRA BIO, INC. Shares Issued
KYNTRA BIO, INC. (KYNB) had Shares Issued of 4.05 million shares as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Equity › Stockholders' Equity, Number of Shares, Par Value and Other Disclosure › Common Stock, Number of Shares, Par Value and Other Disclosure
us-gaap:CommonStockSharesIssued · last filed 2026-08-13
- 2026-06-30: Common Stock, Shares, Issued 4.05M shares.
- 2026-03-31: Common Stock, Shares, Issued 4.05M shares.
- 2025-12-31: Common Stock, Shares, Issued 4.05M shares.
- 2025-09-30: Common Stock, Shares, Issued 4.04M shares.
| Period end | Common Stock, Shares, Issued | Common Stock, Shares, Issued as first filed |
|---|---|---|
| 2026-06-30 | 4.05M shares 10-Q · filed 2026-08-13 | |
| 2026-03-31 | 4.05M shares 10-Q · filed 2026-05-12 | |
| 2025-12-31 | 4.05M shares 10-Q · filed 2026-08-13 | |
| 2025-09-30 | 4.04M shares 10-Q · filed 2025-11-10 | |
| 2025-06-30 | 4.04M shares 10-Q · filed 2025-08-11 | |
| 2025-03-31 | 101.04M shares 10-Q · filed 2025-05-12 | |
| 2024-12-31 | 4.04M shares 10-K · filed 2026-03-16 | 100.92M shares 10-K · filed 2025-03-17 |
| 2024-09-30 | 100.77M shares 10-Q · filed 2024-11-12 | |
| 2024-06-30 | 100.40M shares 10-Q · filed 2024-08-06 | |
| 2024-03-31 | 99.47M shares 10-Q · filed 2024-05-06 | |
| 2023-12-31 | 98.77M shares 10-K · filed 2025-03-17 | |
| 2023-09-30 | 98.34M shares 10-Q · filed 2023-11-06 | |
| 2023-06-30 | 98.20M shares 10-Q · filed 2023-08-07 | |
| 2023-03-31 | 96.62M shares 10-Q · filed 2023-05-08 | |
| 2022-12-31 | 94.17M shares 10-K · filed 2024-02-26 | |
| 2022-09-30 | 93.94M shares 10-Q · filed 2022-11-07 | |
| 2022-06-30 | 93.73M shares 10-Q · filed 2022-08-08 | |
| 2022-03-31 | 93.29M shares 10-Q · filed 2022-05-09 | |
| 2021-12-31 | 92.88M shares 10-K · filed 2023-02-27 | |
| 2021-09-30 | 92.71M shares 10-Q · filed 2021-11-09 | |
| 2021-06-30 | 92.61M shares 10-Q · filed 2021-08-09 | |
| 2021-03-31 | 92.08M shares 10-Q · filed 2021-05-10 | |
| 2020-12-31 | 91.44M shares 10-K/A · filed 2022-03-04 | |
| 2020-09-30 | 90.89M shares 10-Q · filed 2020-11-05 | |
| 2020-06-30 | 90.23M shares 10-Q · filed 2020-08-06 | |
| 2020-03-31 | 88.90M shares 10-Q · filed 2020-05-07 | |
| 2019-12-31 | 87.66M shares 10-K · filed 2021-03-01 | |
| 2019-09-30 | 87.21M shares 10-Q · filed 2019-11-12 | |
| 2019-06-30 | 86.85M shares 10-Q · filed 2019-08-08 | |
| 2019-03-31 | 86.13M shares 10-Q · filed 2019-05-09 | |
| 2018-12-31 | 85.43M shares 10-K · filed 2020-03-02 | |
| 2018-09-30 | 84.85M shares 10-Q · filed 2018-11-08 | |
| 2018-06-30 | 84.18M shares 10-Q · filed 2018-08-07 | |
| 2018-03-31 | 83.42M shares 10-Q · filed 2018-05-09 | |
| 2017-12-31 | 82.50M shares 10-K · filed 2019-02-27 | |
| 2017-09-30 | 81.81M shares 10-Q · filed 2017-11-08 | |
| 2017-06-30 | 70.97M shares 10-Q · filed 2017-08-07 | |
| 2017-03-31 | 64.42M shares 10-Q · filed 2017-05-09 | |
| 2016-12-31 | 63.66M shares 10-K · filed 2018-02-27 | |
| 2016-09-30 | 63.08M shares 10-Q · filed 2016-11-08 | |
| 2016-06-30 | 62.74M shares 10-Q · filed 2016-08-08 | |
| 2016-03-31 | 62.42M shares 10-Q · filed 2016-05-09 | |
| 2015-12-31 | 61.98M shares 10-K · filed 2017-03-01 | |
| 2015-09-30 | 61.24M shares 10-Q · filed 2015-11-12 | |
| 2015-06-30 | 60.37M shares 10-Q · filed 2015-08-13 | |
| 2015-03-31 | 59.27M shares 10-Q · filed 2015-05-12 | |
| 2014-12-31 | 59.05M shares 10-K · filed 2016-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 |